Related systems are disclosed in U.S. patent application Ser. No. 11/497,918 filed Aug. 1, 2006 and titled “Biobriefcase Aerosol Collector” and U.S. patent application Ser. No. 11/497,908 filed Aug. 1, 2006 and titled “Biobriefcase Electrostatic Aerosol Collector Heater.” U.S. patent application Ser. No. 11/497,918 filed Aug. 1, 2006 and titled “Biobriefcase Aerosol Collector” and U.S. patent application Ser. No. 11/497,908 filed Aug. 1, 2006 and titled “Biobriefcase Electrostatic Aerosol Collector Heater” are incorporated herein by this reference.
1. Field of Endeavor
The present invention relates to sampling and more particularly to aerosol sampling.
2. State of Technology
U.S. Pat. No. 6,688,187 issued Feb. 10, 2004 to Donald A. Masquelier for an “Aerosol Sampling System” provides the following state of technology information, “As the threat of biological weapons (BW) increases, both in military theaters and civilian populations, the need for complete systems for the rapid detection and analysis of pathogenic organisms becomes increasingly important. The first step in any system for detection and characterization of biological agents is a sample collector. This can take on the simple form of a cotton swab for solid surfaces, or as in the case of airborne pathogens, an aerosol sample collector is used to collect and concentrate airborne particulate into a liquid sample volume for subsequent preparation and analysis. An aerosol sampler is the most appropriate for continuous monitoring scenarios, where repeated swabbing of settled particles is impractical. Aerosol sampling systems also have use in medical facilities and research and development facilities. There are a variety of medical applications where monitoring for biological pathogens would be useful. A good example of this is monitoring in hospitals and clinics for highly infectious agents such as tuberculosis or nosocomial diseases that can threaten the well being of patients and health care professionals. Aerosol sampling systems also have use in environmental monitoring, that is any application that would benefit from environmental monitoring of biological species. One example is continuous aerosol monitoring of bacterial and other pathogens that could affect the health of livestock (such as the recent hoof and mouth disease outbreak).”
U.S. Pat. No. 6,520,034 issued Feb. 18, 2005 to Donald A. Masquelier et al for a “High Air Volume to Low Liquid Volume Aerosol Collector” provides the following state of technology information, “The first step in any system for detection and characterization of biological agents is a sample collector. This can take on the simple form of a cotton swab for solid surfaces, or as in the case of airborne pathogens, an aerosol sample collector is used to collect and concentrate airborne particulate into a liquid sample volume for subsequent preparation and analysis. An aerosol sampler is the most appropriate for continuous monitoring scenarios, where repeated swabbing of settled particles is impractical. Most commercial samplers now available for field use are large, power consuming, and produce collected sample into large volumes of liquid, typically >10 mL. Emerging miniature detection systems analyze much smaller sample volumes, typically <250 μL. When using the presently available air samplers, the sample volume must be ‘sub-sampled,’ effectively diluting the sample, resulting in a loss of sensitivity of detection. Thus, there is a need for a collector which will collect particulate at a high airflow and yet utilize a low liquid volume.”
Features and advantages of the present invention will become apparent from the following description. Applicants are providing this description, which includes drawings and examples of specific embodiments, to give a broad representation of the invention. Various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this description and by practice of the invention. The scope of the invention is not intended to be limited to the particular forms disclosed and the invention covers all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the claims.
The University of California has operated the Lawrence Livermore National Laboratory continuously since the laboratory's inception in 1952 and has extensive experience and resources in biology, chemistry, engineering, and computations. This gives the University of California and the Lawrence Livermore National Laboratory unique ability to tackle the problems of chemical and biological weapons proliferation and terrorist activities.
In an article titled, “Biodetectors Evolving, Monitoring U.S. Cities,” by Sally Cole in the May 2003 issue of Homeland Security Solutions, it was reported, “The anthrax letter attacks of 2001, and subsequent deaths of five people, brought home the reality of bioterrorism to Americans and provided a wake-up call for the U.S. government about the need for a method to detect and mitigate the impact of any such future attacks. Long before the anthrax letter attacks, scientists at two of the U.S. Department of Energy's national laboratories, Lawrence Livermore National Laboratory (LLNL) and Los Alamos National Laboratory (LANL), were busy pioneering a ‘biodetector’ akin to a smoke detector to rapidly detect the criminal use of biological agents. This technology is now expected to play a large role in the U.S. government's recently unveiled homeland security counter-terrorism initiative, Bio-Watch, which is designed to detect airborne bioterrorist attacks on major U.S. cities within hours. Announced back in January, Bio-Watch is a multi-faceted, multi-agency program that involves the U.S. Department of Energy, the Environmental Protection Agency (EPA), and the U.S. Department of Health and Human Services'Centers for Disease Control and Prevention (CDC). Many of the EPA's 3,000 air-quality monitoring stations throughout the country are being adapted with biodetectors to register unusual quantities of a wide range of pathogens that cause diseases that incapacitate and kill, according to the EPA. The nationwide network of environmental monitors and biodetectors, which reportedly will eventually monitor more than 120 U.S. cities, is expected to detect and report a biological attack within 24 hours. Citing security reasons, the EPA declined to disclose further details about the program at this time . . . .
The Autonomous Pathogen Detection System (APDS) is a file-cabinet-sized machine that sucks in air, runs tests, and reports the results itself. APDS integrates a flow cytometer and real-time PCR detector with sample collection, sample preparation, and fluidics to provide a compact, autonomously operating instrument capable of simultaneously detecting multiple pathogens and/or toxins. ‘The system is designed for fixed locations,’ says Langlois, ‘where it continuously monitors air samples and automatically reports the presence of specific biological agents. APDS is targeted for domestic applications in which the public is at high risk of exposure to covert releases of bioagents—subway systems, transportation terminals, large office complexes, and convention centers . . . . APDS provides the ability to measure up to 100 different agents and controls in a single sample,’ Langlois says. ‘It's being used in public buildings right now.’ The latest evolution of the biodetector, APDS-II, uses bead-capture immunoassays and a compact flow cytometer for the simultaneous identification of multiple biological simulants. Laboratory tests have demonstrated the fully autonomous operation of APDS-II for as long as 24 hours.”
The term “biobriefcase” used in this patent application is intended to mean any device or system for monitoring airborne biological agents in a compact size. One biobriefcase device or system is described in the Sandia National Laboratories Chem/Bio Programs website as follows: “There is a serious need for broad-spectrum bioagent detection. Toward that end, the BioBriefcase project has been undertaken as a joint collaboration between Sandia and Lawrence Livermore National Laboratory for the Department of Homeland Security. It calls for a broad-spectrum bioagent detector that is briefcase-sized and features dramatically reduced reagent consumption, improved sensitivity and rapid response time. Sample preparation and analysis would be carried out on microfluidic, chip-based modules. The detector will use capillary electrophoresis on Sandia's ChemLab platform with three analysis trains; DNA amplification to identify bacteria and viruses using polymerase chain reaction (PCR); immunoassays to identify bacteria, viruses, toxins; and protein signatures to identify toxins. Serving as an environmental monitor, it should function autonomously to collect and detect samples in a stealthy and easily deployed manner. The BioBriefcase should also be capable of being manned by a minimally trained user to function as a portable laboratory, providing quick turn-around between sample analysis and responsive action.”
The first step in any system for detection and characterization of bioagents is an aerosol sampling system that can be used to collect and concentrate airborne particulate into a liquid sample volume for subsequent preparation and analysis. Detection and identification of bioagents in the environment requires the collection and transport of particles into a liquid sample at a concentration exceeding some minimum detectable level. This is typically done with aerosol collectors, of which many types exist. Samples from aerosol collectors are concentrated into a fluid that will be processed and analyzed in a down stream detection system. Often collection systems suffer from low throughput, poor collection efficiency and difficulty operating in dirty environmental conditions.
The present invention provides a system for sampling air and collecting particles entrained in the air. The particles potentially include bioagents. The system comprises a receiving surface, a liquid input that directs liquid to the receiving surface and produces a liquid surface, an air input that directs the air so that the air with particles entrained in the air impact the liquid surface, and an electrostatic contact connected to the liquid that imparts an electric charge to the liquid. The particles potentially including bioagents become captured in the liquid by the air with particles entrained in the air impacting the liquid surface. The electrostatic contact connected to the liquid imparts an electric charge to the liquid. Collection efficiency is improved by the electrostatic contact electrically charging the liquid. The effects of impaction and adhesion due to electrically charging the liquid allows a unique combination in a particle capture medium that has a low fluid consumption rate while maintaining high efficiency.
Organisms that can be collected by the present invention include protein toxins, bacteria, viruses, and chemicals. The present invention can be used to limit or prevent civilian exposure to biological pathogens, and initiate early treatment for those exposed; thereby decreasing mortality and morbidity from bioterrorism events. The present invention also has use in medical facilities and research and development facilities. There are a variety of medical applications where monitoring for biological pathogens is useful. A good example of this is monitoring in hospitals and clinics for highly infectious agents such as tuberculosis or nosocomial diseases that can threaten the well being of patients and health care professionals. The present invention also has use in environmental monitoring, that is any application that would benefit from environmental monitoring of biological species. One example is continuous aerosol monitoring of bacterial and other pathogens that could affect the health of livestock (such as the recent hoof and mouth disease outbreak).
The invention is susceptible to modifications and alternative forms. Specific embodiments are shown by way of example. It is to be understood that the invention is not limited to the particular forms disclosed. The invention covers all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the claims.
The accompanying drawings, which are incorporated into and constitute a part of the specification, illustrate specific embodiments of the invention and, together with the general description of the invention given above, and the detailed description of the specific embodiments, serve to explain the principles of the invention.
Referring to the drawings, to the following detailed description, and to incorporated materials, detailed information about the invention is provided including the description of specific embodiments. The detailed description serves to explain the principles of the invention. The invention is susceptible to modifications and alternative forms. The invention is not limited to the particular forms disclosed. The invention covers all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the claims.
Detection and identification of airborne contaminants and bio-hazards in the environment requires the collection and transport of particles into a liquid sample at a concentration exceeding some minimum detectable level. This is typically done with aerosol collectors, of which many types exist. Samples from aerosol collectors are concentrated into a fluid that will be processed and analyzed in a down stream detection system. Often collection systems suffer from low throughput, poor collection efficiency, and difficulty operating in dirty environmental conditions.
Referring now to the drawings, and more particularly to
The biobriefcase aerosol collector 100 includes a collector that samples the air and collects an air sample that could potentially contain bioagents entrained in the air. An impactor separates the air sample into a first flow portion that does not contain entrained particles and a second flow portion that contains particles that potentially include bioagents. The second portion is directed to a receiving surface. Liquid is directed to the receiving surface and a liquid surface is produced. The second portion of the air sample is directed to the liquid surface so that the second portion of the air sample, with the entrained particles, impacts the liquid surface. The particles, potentially including bioagents, become captured in the liquid. A liquid output port directs the liquid and the particles, potentially including bioagents, captured in the liquid from the receiving surface for analysis.
As illustrated in
The structural components of the biobriefcase aerosol collector 100 having been described, the operation of the biobriefcase aerosol collector 100 will now be considered. As illustrated in
The liquid 112 is directed to the receiving surface 106 of the fluid bowl 105. In the embodiment illustrated in
The particles potentially, including bioagents, become captured in the liquid 112 by the air with particles entrained in the air impacting the liquid surface. The electrostatic contact 114 connected to the liquid 112 imparts an electric charge to the liquid 112. Collection efficiency is improved by the electrostatic contact 114 electrically charging the liquid. The effects of impaction and adhesion due to electrically charging the liquid allows a unique combination in a particle capture medium that has a low fluid consumption rate while maintaining high efficiency.
The biobriefcase aerosol collector 100 has very low fluid consumption. The contacts 104 for fluid level control prevent contamination by debris and allow for high particle concentration rates. The resulting system is a compact, robust, and economical aerosol collector for use in field portable bio-detection systems. There are many uses for the biobriefcase aerosol collector 100. One is for sample collection of bio-hazards in transportation systems or other public environments. Another is for collection of samples for analysis of contamination in human and animal care facilities and distribution centers.
Referring now to
The intake air flow 205 comes in through an intake 208. The forcing cone surface 204 and the bowl surface 203 act together to form an air velocity increase. The velocity of the incoming air can be optimized by shimming the forcing cone 209 relative to the bowl surface 203. This adjustment allows for optimization of the air volume, velocity and liquid surface disruptions. Significant liquid surface disruptions result in fluid loses due to slashing than evaporation. This configuration allows for particle collection with low fluid lost due to splashing. The air volume 206 passes over the liquid surface 207 interacting with the surface at adequate velocity to have the particles ingrain in the liquid 202. Because this device is circular the air volume to liquid volume is very large.
The particles potentially including bioagents become captured in the liquid 202 by the air with particles entrained in the air impacting the liquid surface 207. The electrostatic contact 210 connected to the liquid 202 imparts an electric charge to the liquid 202. Collection efficiency is improved by the electrostatic contact 210 electrically charging the liquid. The effects of impaction and adhesion due to electrically charging the liquid allows a unique combination in a particle capture medium that has a low fluid consumption rate while maintaining high efficiency.
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims.
This application claims the benefit of U.S. Provisional Patent Application No. 60/734,921 filed Nov. 8, 2005 and titled “Biobriefcase Electrostatic Aerosol Collector.” U.S. Provisional Patent Application No. 60/734,921 filed Nov. 8, 2005 and titled “Biobriefcase Electrostatic Aerosol Collector” is incorporated herein by this reference.
The United States Government has rights in this invention pursuant to Contract No. W-7405-ENG-48 between the United States Department of Energy and the University of California for the operation of Lawrence Livermore National Laboratory.
Number | Name | Date | Kind |
---|---|---|---|
4972957 | Liu et al. | Nov 1990 | A |
5317930 | Wedding | Jun 1994 | A |
5412975 | Raabe et al. | May 1995 | A |
6402817 | Bergman | Jun 2002 | B1 |
6520034 | Masquelier et al. | Feb 2003 | B1 |
6688187 | Masquelier | Feb 2004 | B1 |
6692553 | Jordan et al. | Feb 2004 | B2 |
6955075 | Carlson et al. | Oct 2005 | B2 |
7062982 | Coyle et al. | Jun 2006 | B2 |
7140265 | McGill et al. | Nov 2006 | B2 |
7201879 | Hill et al. | Apr 2007 | B2 |
20020045246 | McMillan et al. | Apr 2002 | A1 |
Number | Date | Country |
---|---|---|
WO 02075279 | Sep 2002 | WO |
Number | Date | Country | |
---|---|---|---|
20070107537 A1 | May 2007 | US |
Number | Date | Country | |
---|---|---|---|
60734921 | Nov 2005 | US |